Effect of fenofibrate on the expression of uncoupling protein 3 gene in skeletal muscle of diabetic rats fed with high fat diet

Chinese Pharmacological Bulletin

Volumn 23, Issue 3, 2007, Pages 399-402

  Wei, Cui Feng ^a   Chen, Lu Lu ^a   Wang, Bao Ping ^a   Wu, Qian ^a   Wang, Yong Bo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Diabetes mellitus; Fenofibrate; High fat diet; Rat; Uncoupling protein 3

Indexed keywords

FATTY ACID; FENOFIBRATE; GLUCOSE; INSULIN; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

EID: 34249806697     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Acin A, Rodriguez M, Rique H, et al. Cloning and characterization of the 5′flanking region of the human uncoupling protein3 (UCP3) gene[J]. Biochem Biophys Res Commun, 1999,258(2): 278-83.
2. Reed M J, Meszaros K, Entes L J, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat[J]. Metabolism, 2000, 49(11): 1390-4.
3. Tian A P Guo S S,Shen Z F. Insulin resistant animal model established by high fat diet[J]. Chin Pharmacol Bull, 2006, 22(3) : 267-9.
4. Mori S, Kawano K, Hirashima T, Natori T. Relationships between diet control and the development of spontaneous type 2 diabetes and diabetes nephropathy in OLETF rats [J]. Diabetic Rea Clin Proa, 1996,33(3):145-52.
5. Zhang J Q. HOMA2-IR is a good basal insulin resistance index [J]. Chin J Endocrial Metab,2005,21(4): 304-5.
6. Weigle D S, Selfridge L E, Schwartz M W, et al. Elevated free fatty acids induce uncoupling protein 3 expression in muscle: a potential explanation for the effect of fasting [J]. Diabetes, 1998,47 (2):298-302.
7. Zhou M, Lin B Z, Coughlin S, et al. UCP-3 expression in skeletal muscle: effects of exercise, hypoxia, and AMP-activated protein kinase [J]. Am J Physiol Endocrinol Metab, 2000,279 (3):E622 -9.
8. Schrauwen P, Schaart G, Saris W H, et al. The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in type II diabetic subjects[J]. Diabetologia,2000,43(11):1408-16.
9. Bezaire V, Spriet L L, Campbell S, et al. Constitutive UCP3 over-expression at physiological levels increases mouse skeletal muscle capacity for fatty acid transport and oxidation [J]. FASEB J, 2005,19(8): 977-7.
10. MacLellan J D, Gerrits M F, Gowing A, et al. Physiological increases in uncoupling protein 3 augment fatty acid oxidation and decrease reactive oxygen species production without uncoupling respiration in muscle cells[J]. Diabetes, 2005,54(8):2343-50.
11. Huppertz C, Fischer B M, Kim Y B, et al. Uncoupling protein 3 (UCP3) stimulates glucose uptake in muscle cells through a phosphoinositide 3-kinase-dependent mechanism [J]. J Biol Chem, 2001,20(8):12520-9.
12. Barbe P, Larrouy D, Boulanger C, et al. Triiodothyromine mediated up regulation of UCP2 and UCP3 mRNA expression in human skeletal muscle without coordinated induction of mitochondrial respiratory chain genes[J]. FASEB J, 2001,15(1): 13-5.
13. Clapham J C, Arch J R, Chapman H, et al. Mice overexpressing human uncoupling protein3 in skeletal muscle are hyperphagic and lean [J]. Nature, 2000,406(6794):415-8.
14. Schrauwen P, Hesselink M K, Blaak E E, et al. Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes[J]. Diabetes, 2001,50(12):2870-3.
15. Mensink M, Feskens E J, Saris W H, et al. Study on lifestyle intervention and impaired glucose tolerance Maastricht (SLIM): preliminary results after one year[J]. Int J Obes Relat Metab Disord, 2003,27(3):377-84.